Home › Cancer (all types) › NCT03245411
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
A Randomized, Controlled Trial to Assess Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients in a Socioeconomically Disadvantaged Community
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All patients on oral chemotherapeutic agents * Clinical diagnosis of stage IV breast cancer * Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy) * Clinical diagnosis of stage IV non-small cell lung cancer * Clinical diagnosis of stage IV renal cell carcinoma * Clinical diagnosis of stage IV ovarian carcinoma * Clinical diagnosis of multiple myeloma * Clinical diagnosis of chronic myelogenous leukemia on TKI * Clinical diagnosis of myelodysplastic syndrome on Lenalidomide * Adjuvant treatment for Gastro Intestinal Stromal Tumor * Clinical diagnosis of chronic Lymphocytic Leukemia * Clinical diagnosis of metastatic Prostate cancer * Clinical diagnosis of hepatocellular Carcinoma * Clinical diagnosis of stage IV Melanoma * Clinical diagnosis of myelofibrosis/myeloproliferative neoplasms * Age \>18 years * ECOG Performance Status \<3 Exclusion Criteria: * ECOG Performance Status of 3 and above * Concurrent chemo radiation * Non-English speaker * Clinical diagnosis of dementia, or otherwise unable to give informed consent. * History of non-compliance (defined as the history of 2 or more missed appointments in the clinic). * Pregnant patients * Nursing Home Patients * Incarcerated
About the study
Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.
What is being tested
- Intervention (behavioral)
Sponsor: Thomas Jefferson University · Participants: 110 · Started: Jul 20, 2017
Contact the study team
- Claudia M Dourado, MD · Phone: 215-456-3880
- Claudia Dourado · Phone: 215-456-3880
Official record on ClinicalTrials.gov — NCT03245411
Locations in the U.S.
| Pennsylvania | Albert Einstein Healthcare Network, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.